Your browser doesn't support javascript.
loading
Adherence to protocols for the use of reversal agents in patients treated with direct oral anticoagulants.
Mitrovic, Darko; van Elp, Margriet; Visser, Loes; van Rein, Nienke; van den Bemt, Patricia; van Hulst, Marinus; Dreijer, Albert; Lameijer, Heleen; Veeger, Nic; Meijer, Karina; van Roon, Eric.
Afiliación
  • Mitrovic D; Department of Hospital Pharmacy, Tjongerschans, Heerenveen, The Netherlands.
  • van Elp M; Department of Hospital Pharmacy, Tjongerschans, Heerenveen, The Netherlands.
  • Visser L; Department of Hospital Pharmacy, Haga Hospital, The Hague, The Netherlands.
  • van Rein N; Department of Hospital Pharmacy, University Medical Centre Leiden, Leiden, The Netherlands.
  • van den Bemt P; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.
  • van Hulst M; Department of Hospital Pharmacy, Martini Hospital Groningen, Groningen, The Netherlands.
  • Dreijer A; Department of Hospital Pharmacy, Treant Hospital Emmen, Emmen, The Netherlands.
  • Lameijer H; Department of Hospital Pharmacy, Treant Care Group, Hoogeveen, The Netherlands.
  • Veeger N; Department of Emergency Medicine, Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
  • Meijer K; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • van Roon E; MCL Academy Medical Centre Leeuwarden, Leeuwarden, The Netherlands.
Curr Med Res Opin ; 39(6): 865-871, 2023 06.
Article en En | MEDLINE | ID: mdl-37114434
ABSTRACT

OBJECTIVES:

This study aimed to evaluate the adherence to protocols for the use of reversal agents in direct oral anticoagulant (DOAC) users in Dutch hospitals.

METHODS:

A retrospective cohort study was conducted in seven hospitals in the Netherlands. Treatment protocols for bleeding and (urgent) procedures in patients on DOAC were collected from each hospital. All patient data on the use of reversal agents were retrospectively collected from September 2021 to April 2022 and compared to the protocols. The degree of per-protocol adherence (compliance score) was categorized into four levels as follows poor (<45%), moderate (45-79%), high (80-89%), and full (> 90%) adherence rates.

RESULTS:

A total of 290 patients were included in our study. In patients with bleeding under DOAC, the protocol adherence for prothrombin complex concentrate (PCC) was "moderate" (61%). In the remaining cases (39%), non-adherence was mainly caused by underdosing (68%), overdosing (12%), and a lack of indication (14%). Furthermore, idarucizumab was administered for bleeding with "full" adherence (96%). For andexanet alfa, adherence to the hospital bleeding protocol was "moderate" (67%), with a lack of indication being the only reason for non-adherence. In case of reversal for an urgent procedure, the protocol adherence for PCC was "low" (45%), with underdosing, a lack of indication, and missing lab data being the main reasons for non-adherence. Missing lab data on dabigatran plasma concentration before reversal was the main reason for "low" adherence (26%) in idarucizumab. The adherence for andexanet alfa was also "low" (0%).

CONCLUSION:

In case of reversal for bleeding under DOAC, overall adherence to the protocol was "moderate"; however, in patients needing an urgent procedure, it was "low." The major reasons for non-adherence were underdosing, off-label use, and a lack of specific lab testing. The results of this study can assist in improving the implementation of hospital protocols.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hemorragia / Anticoagulantes Tipo de estudio: Guideline / Observational_studies Límite: Humans Idioma: En Revista: Curr Med Res Opin Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hemorragia / Anticoagulantes Tipo de estudio: Guideline / Observational_studies Límite: Humans Idioma: En Revista: Curr Med Res Opin Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos
...